Pilot study to evaluate safety and efficacy of cabozantinib in aged fragile patients with metastatic renal cell carcinoma. Preliminary results of CABOMAYOR-SOGUG study. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results